Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1975 3
1981 1
1989 2
1990 2
1993 1
1994 1
1995 1
1997 3
1998 5
1999 1
2000 1
2003 1
2004 2
2005 1
2009 1
2010 3
2011 4
2012 4
2013 3
2014 3
2016 1
2018 1
2021 1
2022 2
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Human parvovirus B19 in rheumatoid arthritis.
Takahashi Y, Murai C, Ishii T, Sugamura K, Sasaki T. Takahashi Y, et al. Among authors: murai c. Int Rev Immunol. 1998;17(5-6):309-21. doi: 10.3109/08830189809054408. Int Rev Immunol. 1998. PMID: 10036637 Review.
Oral limaprost for Raynaud's phenomenon.
Murai C, Sasaki T, Osaki H, Hatakeyama A, Shibata S, Yoshinaga K. Murai C, et al. Lancet. 1989 Nov 18;2(8673):1218. doi: 10.1016/s0140-6736(89)91824-2. Lancet. 1989. PMID: 2572927 No abstract available.
Human parvovirus B19 as a causative agent for rheumatoid arthritis.
Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, Saitoh T, Sawai T, Sugamura K, Sasaki T. Takahashi Y, et al. Among authors: murai c. Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8227-32. doi: 10.1073/pnas.95.14.8227. Proc Natl Acad Sci U S A. 1998. PMID: 9653169 Free PMC article.
Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study.
Miyata M, Hirabayashi Y, Munakata Y, Urata Y, Saito K, Okuno H, Yoshida M, Kodera T, Watanabe R, Miyamoto S, Ishii T, Nakazawa S, Takemori H, Ando T, Kanno T, Komagamine M, Kato I, Takahashi Y, Komatsuda A, Endo K, Murai C, Takakubo Y, Miura T, Sato Y, Ichikawa K, Konta T, Chiba N, Muryoi T, Kobayashi H, Fujii H, Sekiguchi Y, Hatakeyama A, Ogura K, Sakuraba H, Asano T, Kanazawa H, Suzuki E, Takasaki S, Asakura K, Suzuki Y, Takagi M, Nakayama T, Watanabe H, Miura K, Mori Y; Michinoku Tocilizumab Study Group. Miyata M, et al. Among authors: murai c. Fukushima J Med Sci. 2023 Apr 5;69(1):11-20. doi: 10.5387/fms.2022-06. Epub 2023 Mar 30. Fukushima J Med Sci. 2023. Retraction in: Fukushima J Med Sci. 2024 Jan 27;70(1):55. doi: 10.5387/fms.retraction. PMID: 36990790 Free PMC article. Retracted.
45 results